Tactile Medical's Participation in an Important Event
Tactile Systems Technology, Inc., known as Tactile Medical, is a prominent player in the medical technology field. This organization specializes in therapies aimed at assisting individuals with chronic disorders. Recently, the company announced its upcoming participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which will be held virtually. This event marks an essential opportunity for Tactile Medical to showcase its innovations to a broader audience.
Event Details and Presentation Schedule
The virtual conference is set to occur from March 17th to March 20th, with Tactile Medical's management scheduled to present on Tuesday, March 18th at 12:00 p.m. Eastern Time. This dedicated time allows the company to discuss its breakthroughs and advancements in the field of medical technology. Those interested in attending will find a live audio webcast available under the “Events & Webcasts” section on Tactile Medical's investor relations website. Additionally, an archive of the presentation will be accessible after the event for those who wish to catch up on the insights shared by the management.
Who is Tactile Medical?
Tactile Medical is dedicated to the development and marketing of at-home therapies designed for individuals suffering from chronic conditions like lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company's mission revolves around improving the quality of life for its patients, offering solutions that allow individuals to manage their health better from the comfort of their homes. By collaborating closely with clinicians, Tactile Medical aims not only to enhance clinical evidence but also to raise awareness and improve access to crucial healthcare solutions.
Impact on Healthcare and Patient Care
Throughout its operation, Tactile Medical has helped tens of thousands of patients live better lives and engage in self-care practices at home. By expanding clinical evidence and making therapies more accessible, Tactile Medical plays a critical role in reducing overall healthcare costs while enhancing patient care. Their commitment to addressing underserved chronic conditions reflects a broader vision for healthcare, one where patients can take charge of their well-being with the right support and resources.
Investor Inquiries and Further Information
For those looking to get in touch with Tactile Medical for investor inquiries or further questions regarding their offerings, Sam Bentzinger from the Gilmartin Group is available for assistance. Interested parties can reach out via email at investorrelations@tactilemedical.com.
Frequently Asked Questions
What is the main focus of Tactile Medical?
Tactile Medical focuses on creating therapies for individuals with chronic conditions, particularly those that can benefit from at-home care solutions.
When will Tactile Medical present at the conference?
They will present on March 18th at 12:00 p.m. Eastern Time during the Oppenheimer conference.
How can I access the presentation?
A live audio webcast will be available on Tactile Medical's investor relations website.
What chronic conditions does Tactile Medical address?
The company offers therapies for lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.
Who can I contact for investor inquiries?
Contact Sam Bentzinger at Gilmartin Group via email at investorrelations@tactilemedical.com for any inquiries.